{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:01:33Z","timestamp":1790791293758,"version":"4.1.0"},"reference-count":184,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T00:00:00Z","timestamp":1695340800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T00:00:00Z","timestamp":1695340800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006400","name":"Alnylam Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006400","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Hereditary and wild-type transthyretin-mediated (ATTRv and ATTRwt) amyloidoses result from the misfolding of transthyretin and aggregation of amyloid plaques in multiple organ systems. Diagnosis of ATTR amyloidosis is often delayed due to its heterogenous and non-specific presentation. This review investigates the association of musculoskeletal (MSK) manifestations with ATTR amyloidosis and the delay from the onset of these manifestations to the diagnosis of ATTR amyloidosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This systematic review utilized Medline and EMBASE databases. Search criteria were outlined using a pre-specified patient, intervention, comparator, outcome, time, study (PICOTS) criteria and included: amyloidosis, ATTR, and MSK manifestations. Publication quality was assessed utilizing Joanna Briggs Institute (JBI) critical appraisal checklists.<\/jats:p><jats:p>The search initially identified 7,139 publications, 164 of which were included. PICOTS criteria led to the inclusion of epidemiology, clinical burden and practice, pathophysiology, and temporality of MSK manifestations associated with ATTR amyloidosis. 163 publications reported on ATTR amyloidosis and MSK manifestations, and 13 publications reported on the delay in ATTR amyloidosis diagnosis following the onset of MSK manifestations.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The MSK manifestation most frequently associated with ATTR amyloidosis was carpal tunnel syndrome (CTS); spinal stenosis (SS) and osteoarthritis (OA), among others, were also identified. The exact prevalence of different MSK manifestations in patients with ATTR amyloidosis remains unclear, as a broad range of prevalence estimates were reported. Moreover, the reported prevalence of MSK manifestations showed no clear trend or distinction in association between ATTRv and ATTRwt amyloidosis.<\/jats:p><jats:p>MSK manifestations precede the diagnosis of ATTR amyloidosis by years, and there was substantial variation in the reported delay to ATTR amyloidosis diagnosis. Reports do suggest a longer diagnostic delay in patients with ATTRv amyloidosis, with 2 to 12 years delay in ATTRv versus 1.3 to 1.9 years delay in ATTRwt amyloidosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>These findings suggest that orthopedic surgeons may play a role in the early diagnosis of and treatment referrals for ATTR amyloidosis. Detection of MSK manifestations may enable earlier diagnosis and administration of effective treatments before disease progression occurs.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12891-023-06853-5","type":"journal-article","created":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T12:02:57Z","timestamp":1695384177000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Musculoskeletal manifestations associated with transthyretin-mediated (ATTR) amyloidosis: a systematic review"],"prefix":"10.1186","volume":"24","author":[{"given":"Emre","family":"Aldinc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Finn","family":"Gustafsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"Beveridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Macey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Marr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Summers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dafang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,22]]},"reference":[{"issue":"10","key":"6853_CR1","doi-asserted-by":"crossref","first-page":"e488","DOI":"10.5435\/JAAOS-D-20-01146","volume":"29","author":"D Zhang","year":"2021","unstructured":"Zhang D, Makhni MC, Kang JD, Blazar P. Orthopaedic manifestations of amyloidosis. JAAOS-Journal of the American Academy of Orthopaedic Surgeons. 2021;29(10):e488\u201396.","journal-title":"JAAOS-Journal of the American Academy of Orthopaedic Surgeons"},{"issue":"3","key":"6853_CR2","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/joim.13169","volume":"289","author":"E Muchtar","year":"2021","unstructured":"Muchtar E, Dispenzieri A, Magen H, Grogan M, Mauermann M, McPhail E, Kurtin P, Leung N, Buadi F, Dingli D. Systemic amyloidosis from A (AA) to T (ATTR): a review. J Intern Med. 2021;289(3):268\u201392.","journal-title":"J Intern Med"},{"issue":"4","key":"6853_CR3","first-page":"537","volume":"3","author":"J Nativi-Nicolau","year":"2021","unstructured":"Nativi-Nicolau J, Siu A, Dispenzieri A, Maurer MS, Rapezzi C, Kristen AV, Garcia-Pavia P, LoRusso S, Waddington-Cruz M, Lairez O. Temporal trends of wild-type transthyretin amyloid cardiomyopathy in the transthyretin amyloidosis outcomes survey. Cardio Oncol. 2021;3(4):537\u201346.","journal-title":"Cardio Oncol"},{"issue":"3","key":"6853_CR4","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.cjca.2019.12.033","volume":"36","author":"SA Cuddy","year":"2020","unstructured":"Cuddy SA, Falk RH. Amyloidosis as a systemic disease in context. Can J Cardiol. 2020;36(3):396\u2013407.","journal-title":"Can J Cardiol"},{"issue":"1","key":"6853_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13506129.2022.2091985","volume":"30","author":"D Adams","year":"2023","unstructured":"Adams D, Tournev IL, Taylor MS, Coelho T, Plant\u00e9-Bordeneuve V, Berk JL, Gonz\u00e1lez-Duarte A, Gillmore JD, Low S-C, Sekijima Y, et al. Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial. Amyloid. 2023;30(1):1\u20139.","journal-title":"Amyloid."},{"issue":"1","key":"6853_CR6","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S1474-4422(20)30368-9","volume":"20","author":"D Adams","year":"2021","unstructured":"Adams D, Polydefkis M, Gonz\u00e1lez-Duarte A, Wixner J, Kristen AV, Schmidt HH, Berk JL, Losada L\u00f3pez IA, Dispenzieri A, Quan D, et al. Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study. Lancet Neurol. 2021;20(1):49\u201359.","journal-title":"Lancet Neurol"},{"issue":"1","key":"6853_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-021-01706-7","volume":"16","author":"D Rintell","year":"2021","unstructured":"Rintell D, Heath D, Braga Mendendez F, Cross E, Cross T, Knobel V, Gagnon B, Turtle C, Cohen A, Kalmykov E. Patient and family experience with transthyretin amyloid cardiomyopathy (ATTR-CM) and polyneuropathy (ATTR-PN) amyloidosis: results of two focus groups. Orphanet J Rare Dis. 2021;16(1):1\u201313.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"6853_CR8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","volume":"379","author":"D Adams","year":"2018","unstructured":"Adams D, Gonzalez-Duarte A, O\u2019Riordan WD, Yang C-C, Ueda M, Kristen AV, Tournev I, Schmidt HH, Coelho T, Berk JL, et al. Patisiran, an RNAi therapeutic, for Hereditary Transthyretin Amyloidosis. N Engl J Med. 2018;379(1):11\u201321.","journal-title":"N Engl J Med"},{"issue":"1","key":"6853_CR9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/2047-9158-3-19","volume":"3","author":"M Ueda","year":"2014","unstructured":"Ueda M, Ando Y. Recent advances in transthyretin amyloidosis therapy. Translational Neurodegeneration. 2014;3(1):19.","journal-title":"Translational Neurodegeneration"},{"issue":"9","key":"6853_CR10","first-page":"e006075","volume":"12","author":"MS Maurer","year":"2019","unstructured":"Maurer MS, Bokhari S, Damy T, Dorbala S, Drachman BM, Fontana M, Grogan M, Kristen AV, Lousada I, Nativi-Nicolau J. Expert consensus recommendations for the suspicion and diagnosis of transthyretin cardiac amyloidosis. Circulation: Heart Failure. 2019;12(9):e006075.","journal-title":"Circulation: Heart Failure"},{"issue":"3","key":"6853_CR11","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s10741-021-10080-2","volume":"27","author":"JN Nativi-Nicolau","year":"2022","unstructured":"Nativi-Nicolau JN, Karam C, Khella S, Maurer MS. Screening for ATTR amyloidosis in the clinic: overlapping disorders, misdiagnosis, and multiorgan awareness. Heart Fail Rev. 2022;27(3):785\u201393.","journal-title":"Heart Fail Rev"},{"issue":"1","key":"6853_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13643-020-01552-x","volume":"10","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Reviews. 2021;10(1):1\u201311.","journal-title":"Syst Reviews"},{"key":"6853_CR13","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ijsu.2018.10.028","volume":"60","author":"RA Agha","year":"2018","unstructured":"Agha RA, Borrelli MR, Farwana R, Koshy K, Fowler AJ, Orgill DP, Zhu H, Alsawadi A, Noureldin A, Rao A. The SCARE 2018 statement: updating consensus Surgical CAse REport (SCARE) guidelines. Int J Surg. 2018;60:132\u20136.","journal-title":"Int J Surg"},{"issue":"1","key":"6853_CR14","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/pin.13041","volume":"71","author":"RK Abe","year":"2021","unstructured":"Abe RK, Takahashi N, Takasone Y, Yoshinaga K, Yazaki T, Kametani M, Sekijima F. Distribution of amyloidosis subtypes based on tissue biopsy site - consecutive analysis of 729 patients at a single amyloidosis center in Japan. Pathol Int. 2021;71(1):70\u20139.","journal-title":"Pathol Int"},{"key":"6853_CR15","doi-asserted-by":"crossref","unstructured":"Akinboboye OA, Malik K, Warner A, Karsten A, Damy V, Taylor T, Maurer HA. M. S.: DISCOVERY: A study examining the prevalence of transthyretin mutations in subjects suspected of having cardiac amyloidosis. Orphanet J Rare Dis. 2015;10(Suppl 1):O8.","DOI":"10.1186\/1750-1172-10-S1-O8"},{"issue":"1","key":"6853_CR16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/ncn3.12384","volume":"9","author":"YY Ando","year":"2021","unstructured":"Ando YY, Misumi T, Nomura Y, Sasada T, Okada K, Inoue M, Masuda Y, Ueda T, Takamatsu A, Obayashi K, Matsui K, Naiki H, Ueda H. Clinical, pathological, and proteomic characteristics of newly diagnosed amyloidosis patients: experience from a single referral center in Japan. Neurol Clin Neurosci. 2021;9(1):37\u201344","journal-title":"Neurol Clin Neurosci"},{"key":"6853_CR17","unstructured":"Arevalo. Carpal tunnel syndrome related to cardiac amyloidosis. In: International Society of Amyloidosis vol.\u00a0XVII International Symposium on Amyloidosis. Spain 2020 529."},{"issue":"3","key":"6853_CR18","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1080\/13506129.2018.1498782","volume":"25","author":"EB Bishop","year":"2018","unstructured":"Bishop EB, Fajardo EE, Barouch J, Judge LA, Halushka DP. Seven factors predict a delayed diagnosis of cardiac amyloidosis. Amyloid. 2018;25(3):174\u20139.","journal-title":"Amyloid"},{"issue":"Supplement 1","key":"6853_CR19","first-page":"659","volume":"61","author":"SB Bukhari","year":"2020","unstructured":"Bukhari SB, Nieves A, Eisele R, Follansbee Y, Soman WP. Clinical Predictors of positive 99mTc-99m pyrophosphate scan in patients hospitalized for decompensated heart failure. J Nucl Med. 2020;61(Supplement 1):659.","journal-title":"J Nucl Med."},{"issue":"18 Supplement 1","key":"6853_CR20","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0735-1097(21)02034-9","volume":"77","author":"SF Bukhari","year":"2021","unstructured":"Bukhari SF, Brownell S, Eisele A, Soman YS. Race-specific phenotypic and genotypic comparison of patients with Transthyretin Cardiac Amyloidosis. J Am Coll Cardiol. 2021;77(18 Supplement 1):675.","journal-title":"J Am Coll Cardiol"},{"issue":"S1","key":"6853_CR21","first-page":"S27","volume":"14","author":"MF Cappellari","year":"2009","unstructured":"Cappellari MF, Taioli M, Cavallaro F, Ferrari T, Rizzuto S, Fabrizi NGM. Diagnostic pitfalls in transthyretin-related familial amyloid polyneuropathies (TTR-FAPS). J Peripheral Nerv Syst. 2009;14(S1):S27-8.","journal-title":"J Peripheral Nerv Syst."},{"issue":"2","key":"6853_CR22","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1529-8027.2011.00331.x","volume":"16","author":"MC Cappellari","year":"2011","unstructured":"Cappellari MC, Ferrarini T, Cabrini M, Taioli I, Ferrari F, Merlini S, Obici G, Briani L, Fabrizi C. Variable presentations of TTR-related familial amyloid polyneuropathy in seventeen patients. J Peripheral Nerv Syst. 2011;16(2):119\u201329.","journal-title":"J Peripheral Nerv Syst"},{"issue":"6","key":"6853_CR23","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/joim.13200","volume":"289","author":"FZ Cappelli","year":"2021","unstructured":"Cappelli FZ, Fumagalli M, Nardi C, Del Monaco G, Matucci Cerinic G, Allinovi M, Taborchi M, Martone G, Gabriele R, Ungar M, Moggi Pignone A, Marchionni A, Di Mario N, Olivotto C, Perfetto I. Tenosynovial complications identify TTR cardiac amyloidosis among patients with hypertrophic cardiomyopathy phenotype. J Intern Med. 2021;289(6):831\u20139.","journal-title":"J Intern Med"},{"issue":"Supplement 1","key":"6853_CR24","first-page":"100","volume":"7","author":"EA Cerudelli","year":"2019","unstructured":"Cerudelli EA, Gazzilli D, Bonacina M, Durmo M, Dondi R, Mazzoletti F, Bertagna A, Giubbini F. Transthyretin cardiac amyloidosis and aortic stenosis: in which patients we have to suspect a coexistence. Clin Translational Imaging. 2019;7(Supplement 1):100\u2013S101.","journal-title":"Clin Translational Imaging"},{"issue":"4","key":"6853_CR25","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3233\/JND-210656","volume":"8","author":"ZK Chen","year":"2021","unstructured":"Chen ZK, Saini JS, Tay M, Jayne Tan KSS, Chai Y, Fam JYH, Juraidah SR, Lim AR, Ng PK, Prasad ASL, Tan K, Umapathi CB, Verma T, Yong KK, Yu MH, Ng C. Hereditary Transthyretin Amyloidosis- Clinical and genetic characteristics of a Multiracial South-East Asian Cohort in Singapore. J Neuromuscul Dis. 2021;8(4):723\u201333.","journal-title":"J Neuromuscul Dis"},{"key":"6853_CR26","doi-asserted-by":"crossref","unstructured":"Choi. \u201cThe giant awakes\u201d \u2013 rapid increases in the diagnosis of transthyretin (ttr) amyloidosis after the attr-act trial of tafamidis. In: International Society of Amyloidosis vol. XVII International Symposium on Amyloidosis. Spain. 2020;29(Supplement 2):S115 529.","DOI":"10.1016\/j.hlc.2020.09.185"},{"issue":"SUPPL J","key":"6853_CR27","first-page":"J178","volume":"21","author":"AC Cipriani","year":"2019","unstructured":"Cipriani AC, Civera M, De Michieli S, Cecchin L, Pilichou D, Babuin K, Marra L, Iliceto MP, Briani S, Calore C. Diagnostic approach to wild-type transthyretin cardiac amyloidosis. A single-centre experience. Eur Heart J Supplement. 2019;21(SUPPL J):J178\u20139.","journal-title":"Eur Heart J Supplement"},{"issue":"S1","key":"6853_CR28","first-page":"S27","volume":"14","author":"AO Cortese","year":"2009","unstructured":"Cortese AO, Palladini L, Milani G, Sforzini P, Perlini C, Verga S, Lavatelli L, Casarini F, Merlini SG. Clinical and demographic aspects of ATTR amyloidosis: genetic heterogeneity, prognostic markers and novel therapeutic approaches. J Peripheral Nerv Syst. 2009;14(S1):S27\u20138.","journal-title":"J Peripheral Nerv Syst."},{"issue":"S2","key":"6853_CR29","first-page":"S382","volume":"37","author":"FG Minutoli","year":"2010","unstructured":"Minutoli FG, Di Bella M, Crisafulli G, Mure C, Militano G, Brancati V, Di Leo M, Mazzeo R, Baldari AS. Cardiac involvement in transthyretin familial amyloid polyneuropathy - comparison between 99mTc-DPD SPECT and magnetic resonance imaging. Eur J Nucl Med Mol Imaging. 2010;37(S2):S382\u20133.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"6853_CR30","first-page":"831","volume":"8","author":"KL Du","year":"2021","unstructured":"Du KL, Wang F, Miao H, Lv Y, Zhang H, Wang W, Yuan Z, Meng Y. Hereditary transthyretin amyloidosis in mainland China: a unicentric retrospective study. Ann. 2021;8(4):831\u201341.","journal-title":"Ann"},{"key":"6853_CR31","doi-asserted-by":"crossref","unstructured":"Durmus HM, Atmaca Z, Poda MM, Oflazer-Serdarotlu M, Deymeer P, Parman FY. Genotypic and phenotypic presentation of TTR-FAP in Turkey. J Neurol. 2015;84(14 Supplement):P2.034.","DOI":"10.1212\/WNL.84.14_supplement.P2.034"},{"issue":"6","key":"6853_CR32","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/ane.13507","volume":"144","author":"HC Durmus","year":"2021","unstructured":"Durmus HC, Demirci A, Alaylioglu H, Gezen-Ak M, Dursun D, Gulsen Parman E. An exploratory study of cognitive involvement in Hereditary Transthyretin Amyloidosis. Acta Neurol Scand. 2021;144(6):640\u20136.","journal-title":"Acta Neurol Scand"},{"key":"6853_CR33","doi-asserted-by":"crossref","unstructured":"Erdogan CB, Uluc AO, Karli K, Koc N, Ozturk F, Sengun S, Secil IS, Tutuncu Y, Akalin M, Uysal MA, Ozdamar H, Parman SE. Y. Transthyretin familial amyloid polyneuropathy (TTR-FAP): A database analysis. Neurology Conference: 72nd Annual Meeting of the American Academy of Neurology, AAN. 2020;94(15 Supplement):3987.","DOI":"10.1212\/WNL.94.15_supplement.3987"},{"issue":"1","key":"6853_CR34","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/PAS.0b013e3181788566","volume":"33","author":"MB Eriksson","year":"2009","unstructured":"Eriksson MB, Todorov J, Yumlu T, Schonland S, Hegenbart S, Kristen U, Dengler AV, Lohse T, Helmke P, Schmidt B, Rocken H. Prevalence of germline mutations in the TTR gene in a consecutive series of surgical pathology specimens with ATTR ayloid. Am J Surg Pathol. 2009;33(1):58\u201365.","journal-title":"Am J Surg Pathol"},{"issue":"8 Supplement","key":"6853_CR35","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.cardfail.2019.07.023","volume":"25","author":"AD Gabrovsek","year":"2019","unstructured":"Gabrovsek AD, Estep JP, Perez J, Tang A, Hanna WHW. Transthyretin Cardiac Amyloidosis in the Black Population: a ten-year experience. J Card Fail. 2019;25(8 Supplement):6.","journal-title":"J Card Fail"},{"issue":"10","key":"6853_CR36","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1002\/ejhf.1285","volume":"20","author":"CP Gagliardi","year":"2018","unstructured":"Gagliardi CP, Lorenzini F, Ferlini M, Salvi A, Milandri F, Quarta A, Taborchi CC, Bartolini G, Frusconi S, Martone S, Cinelli R, Foffi MM, Reggiani S, Fabbri MLB, Cataldo G, Cappelli P, Rapezzi F. Phenotypic profile of Ile68Leu transthyretin amyloidosis: an underdiagnosed cause of heart failure. Eur J Heart Fail. 2018;20(10):1417\u201325.","journal-title":"Eur J Heart Fail"},{"issue":"47","key":"6853_CR37","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1093\/eurheartj\/ehw033","volume":"37","author":"AG Galat","year":"2016","unstructured":"Galat AG, Bodez A, Slama D, Dijos M, Zeitoun M, Milleron DM, Attias O, Dubois-Rande D, Mohty JL, Audureau D, Teiger E, Rosso E, Monin J, Damy JL. Aortic stenosis and transthyretin cardiac amyloidosis: the chicken or the egg? Eur Heart J. 2016;37(47):3525\u201331.","journal-title":"Eur Heart J"},{"issue":"Supplement 1","key":"6853_CR38","first-page":"28","volume":"76","author":"MF Gawor","year":"2018","unstructured":"Gawor MF, Sioma M, Mazurkiewicz A, Lipowska L, Ojrzynska M, Szczygiel N, Spiewak J, Marczak M, Bilinska M, Grzybowski Z. Genetic diagnosis in transthyretin cardiac amyloidosis - A single centre experience. Kardiologia Polska. 2018;76(Supplement 1):28\u20139.","journal-title":"Kardiologia Polska"},{"issue":"Supplement 1","key":"6853_CR39","first-page":"139","volume":"77","author":"MS Gawor","year":"2019","unstructured":"Gawor MS, Marczak A, Teresinska M, Grzybowski A. It is not so rare to have a rare disease: single centre experience with wild type transthyretin amyloid cardiomyopathy. Kardiologia Polska. 2019;77(Supplement 1):139\u201340.","journal-title":"Kardiologia Polska"},{"key":"6853_CR40","unstructured":"Gawor. Rare transthyretin gene mutations: phe33leu, glu89lys and ala81val in patients with cardiac transthyretin amyloidosis- single centre experience. In: International Society of Amyloidosis vol. XVII International Symposium on Amyloidosis. Spain; 2020. p. PM091."},{"issue":"3","key":"6853_CR41","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/jns.12385","volume":"25","author":"LDB Gentile","year":"2020","unstructured":"Gentile LDB, Minutoli G, Cucinotta F, Obici F, Mussinelli L, Arimatea R, Russo I, Toscano M, Vita A, Mazzeo G. Description of a large cohort of caucasian patients with V122I ATTRv amyloidosis: neurological and cardiological features. J Peripheral Nerv Syst. 2020;25(3):273\u20138.","journal-title":"J Peripheral Nerv Syst"},{"issue":"SUPPL 1","key":"6853_CR42","first-page":"859","volume":"42","author":"CA Goena","year":"2021","unstructured":"Goena CA, Villanueva X, Solla I, Rengel I, Querejeta A. Are there predictor variables for the diagnosis of transthyretin cardiac amyloidosis? Eur Heart J. 2021;42(SUPPL 1):859.","journal-title":"Eur Heart J"},{"key":"6853_CR43","doi-asserted-by":"crossref","unstructured":"Gospodinova MS, Guergueltcheva S, Kirov V, Chamova A, Todorova T, Tournev A, Denchev IS. Cardiomyopathy and peripheral polyneuropathy severity in patients with Glu89Gln mutation at the time of diagnosis.\u00a0\u00a0Conference: 1st European Congresson Hereditary ATTR Amyloidosis. Paris France.\u00a0Orphanet J Rare Dis. 2015;10(Supplement 1):59.","DOI":"10.1186\/1750-1172-10-S1-P59"},{"issue":"10 Supplement","key":"6853_CR44","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cardfail.2020.09.101","volume":"26","author":"KM Hewitt","year":"2020","unstructured":"Hewitt KM, Giblin M, Murphy G, Joyce L. The clinical spectrum of T60a variant Hereditary Transthyretin Amyloidosis in Ireland. J Card Fail. 2020;26(10 Supplement):33.","journal-title":"J Card Fail"},{"issue":"1","key":"6853_CR45","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/CND.0000000000000356","volume":"23","author":"Y Hussain","year":"2021","unstructured":"Hussain Y. Variable presentation of Hereditary transthyretin-mediated amyloidosis at a single Center. J Clin Neuromuscul Dis. 2021;23(1):7\u201317.","journal-title":"J Clin Neuromuscul Dis"},{"issue":"1","key":"6853_CR46","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13023-020-1309-9","volume":"15","author":"AE Jercan","year":"2020","unstructured":"Jercan AE, Jurcut A, Draghici R, Badelita M, Dragomir S, Dobrea M, Popescu C, Jardan M, Stoica D, Iacob E, Codita S, Stan I, Coriu C. Clinical characteristics in patients with hereditary amyloidosis with Glu54Gln transthyretin identified in the romanian population. Orphanet J Rare Dis. 2020;15(1):34.","journal-title":"Orphanet J Rare Dis"},{"key":"6853_CR47","unstructured":"Kaku. Neurological manifestations in patients with hereditary transthyretin amyloidosis: a major multidisciplinary center experience. In: International Society of Amyloidosis vol. XVII International Symposium on Amyloidosis. Spain; 2020. p. PM093."},{"key":"6853_CR48","doi-asserted-by":"crossref","unstructured":"Kalinoski-Dubose VL, Efebera S, Parikh Y, Almaani S, Sharma S, Redder N, Freimer E, Bumma M, Kahwash N, Vallakati R, Campbell AC. Phenotypically Sex Differences in Transthyretin Amyloidosis V122I Mutation Patients. Circulation Conference: American Heart Association Scientific Sessions, AHA. 2020;142(SUPPL 3):A17058-A17058.","DOI":"10.1161\/circ.142.suppl_3.17058"},{"issue":"4","key":"6853_CR49","first-page":"309","volume":"9","author":"CD Karam","year":"2019","unstructured":"Karam CD, Christ D, Heitner M. Carpal tunnel syndrome and associated symptoms as first manifestation of hATTR amyloidosis. Neurol. 2019;9(4):309\u201313.","journal-title":"Neurol"},{"issue":"SUPPL 1","key":"6853_CR50","first-page":"1808","volume":"42","author":"AS Keller","year":"2021","unstructured":"Keller AS, Delgado K, Vallakati D, Akinboboye A, Towne O, Olugemo M, Narayana K. Clinical characteristics of patients with hereditary transthyretin mutations primarily associated with cardiomyopathy and other rare transthyretin mutations: insights from a genetic testing programme. Eur Heart J. 2021;42(SUPPL 1):1808.","journal-title":"Eur Heart J"},{"issue":"8 Supplement","key":"6853_CR51","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.cardfail.2019.07.170","volume":"25","author":"ASY Kessler","year":"2019","unstructured":"Kessler ASY, Pollock A, Guthrie M, McCausland S. Characterizing the journey to diagnosis for patients with Transthyretin Amyloidosis and Accompanying Congestive Heart failure. J Card Fail. 2019;25(8 Supplement):60.","journal-title":"J Card Fail"},{"issue":"3","key":"6853_CR52","first-page":"390","volume":"26","author":"SS Khella","year":"2021","unstructured":"Khella SS, Delgado K, Marti D, Keller C, Jefferies A, Towne J, Gabriel M, Narayana A, Olugemo A. Clinical characteristics of patients with transthyretin gene mutations and polyneuropathy manifestations of hereditary transthyretin amyloidosis. J Peripheral Nerv Syst. 2021;26(3):390\u20131.","journal-title":"J Peripheral Nerv Syst"},{"issue":"SUPPL 1","key":"6853_CR53","first-page":"805","volume":"28","author":"SD Khella","year":"2021","unstructured":"Khella SD, Towne U, Narayana M, Olugemo A. Hereditary transthyretin amyloidosis and other neuromuscular diseases. Eur J Neurol. 2021;28(SUPPL 1):805.","journal-title":"Eur J Neurol"},{"issue":"SUPPL 1","key":"6853_CR54","first-page":"422","volume":"28","author":"SD Khella","year":"2021","unstructured":"Khella SD, Gertz D, Towne M, Narayana M, Olugemo A. Characteristics of patients with p.V50M and p.T80A mutations associated with hereditary transthyretin amyloidosis. Eur J Neurol. 2021;28(SUPPL 1):422.","journal-title":"Eur J Neurol"},{"issue":"18 Supplement 1","key":"6853_CR55","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/S0735-1097(21)02247-6","volume":"77","author":"AS Keller","year":"2021","unstructured":"Keller AS, Delgado KB, Vallakati D, Akinboboye A, Marti O, Dolinsky C, Gabriel J, Narayana A, Olugemo A. Genotypic and phenotypic differences and similarities among patients with Transthyretin Amyloidosis or other inherited Cardiovascular Diseases: insights from a genetic testing program. J Am Coll Cardiol. 2021;77(18 Supplement 1):888.","journal-title":"J Am Coll Cardiol"},{"key":"6853_CR56","doi-asserted-by":"crossref","unstructured":"Kristen AVH, Schnabel S, Rocken P, Hardt C, Altland S, Katus K, Dengler HA. TJ. Scintigraphic heart retention and annular plane systolic excursion predict outcome in patients with senile systemic amyloidosis. J Heart Lung Transplant. 2010;29(2 Supplement):S24.","DOI":"10.1016\/j.healun.2009.11.063"},{"key":"6853_CR57","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0735-1097(16)31544-3","volume":"1","author":"AVB Kristen","year":"2016","unstructured":"Kristen AVB, Aus Dem Siepen R, Hein F, Aurich S, Riffel M, Katus J, Buss HA. Risk stratification in wild-type transthyretin amyloidosis. J Am Coll Cardiol. 2016;1:1543.","journal-title":"J Am Coll Cardiol"},{"issue":"12 Supplement 1","key":"6853_CR58","first-page":"133S","volume":"20","author":"GM La Malfa","year":"2019","unstructured":"La Malfa GM, Rizzola A, Vianello G, Tini PF, Porto G, Brunelli I, Sambuceti C, Capitanio G, Canepa S. Wrist tracer uptake in transthyretin amyloidosis cardiomyopathy patients diagnosed using bone scintigraphy. G Ital Cardiol. 2019;20(12 Supplement 1):133S.","journal-title":"G Ital Cardiol"},{"key":"6853_CR59","first-page":"1085","volume":"1","author":"SQ Longhi","year":"2014","unstructured":"Longhi SQ, Gagliardi CC, Milandri C, Gentile A, Manuzzi N, Lorenzini L, Bartolomei M, Salvi I, Rapezzi F. Carpal tunnel syndrome in amyloidosis: prevalence, risk factors and correlation with cardiac involvement in a large cohort of 435 consecutive patients. Eur Heart J. 2014;1:1085.","journal-title":"Eur Heart J"},{"key":"6853_CR60","doi-asserted-by":"crossref","unstructured":"Longhi SM, Gagliardi A, Lorenzini C, Saia M, Leone F, Guidalotti O, Rapezzi PLC. Coexistence of degenerative aortic stenosis and wild type transthyretin-related cardiac amyloidosis: A potentially dangerous association that can be non-invasively identified.\u00a0Orphanet J Rare Dis. 2015;10(Suppl 1):P45.","DOI":"10.1186\/1750-1172-10-S1-P45"},{"key":"6853_CR61","first-page":"S33","volume":"1","author":"MC Luigetti","year":"2012","unstructured":"Luigetti MC, Del Grande A, Bisogni A, Romano G, Marcaccio A, Lo Monaco A, Laurenti M, Obici L, Merlini L, Sabatelli GM. Ttr-related amyloid neuropathy: cliniclectrophysiological and pathological findings in fifteen unrelated patients. J Peripheral Nerv Syst. 2012;1:S33-4.","journal-title":"J Peripheral Nerv Syst."},{"issue":"8 Supplement","key":"6853_CR62","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cardfail.2019.07.318","volume":"25","author":"RT Malladi","year":"2019","unstructured":"Malladi RT, Winder R, Dinh T, Melanson Q, Agarwal M. Alnylam Act: Heterogenous Disease Manifestations of Hereditary transthyretin-mediated amyloidosis. J Card Fail. 2019;25(8 Supplement):111\u2013S112.","journal-title":"J Card Fail"},{"issue":"SUPPL J","key":"6853_CR63","first-page":"J183","volume":"21","author":"RB Martone","year":"2019","unstructured":"Martone RB, De Los Santos J, Gagliardi J, Caponetti C, Perfetto G, Di Mario F, Marcucci C, Rapezzi R, Maurer C, Cappelli MF. Effect of ethnic background on phenotype at presentation in V122i-related hereditary cardiac amyloidosis. Eur Heart J Supplement. 2019;21(SUPPL J):J183.","journal-title":"Eur Heart J Supplement"},{"issue":"Supplement 1","key":"6853_CR64","first-page":"i529","volume":"20","author":"EG Merli","year":"2019","unstructured":"Merli EG, Antonopoulos I, Pontone A, Cicchitelli G, Amadei G, Fabbri G, Del Giudice E. Myocardial distribution of 99mTc-HMDP and regional longitudinal strain in aTTR amyloidosis cardiomyopathy. Eur Heart J Cardiovasc Imaging. 2019;20(Supplement 1):i529.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"3","key":"6853_CR65","first-page":"281","volume":"21","author":"AG Milandri","year":"2016","unstructured":"Milandri AG, Mazzeo M, Alfonzo A, Stancanelli A, Vita C, Rapezzi G, Tournev C. Transthyretin-related amyloidosis in the mediterranean and balkan area: focus on the GLU89GLN mutation. J Peripheral Nerv Syst. 2016;21(3):281.","journal-title":"J Peripheral Nerv Syst"},{"issue":"1","key":"6853_CR66","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3109\/13506129.2015.1135792","volume":"23","author":"MS Nakagawa","year":"2016","unstructured":"Nakagawa MS, Yazaki Y, Tojo M, Yoshinaga K, Doden T, Koyama T, Yanagisawa J, Ikeda S. Carpal tunnel syndrome: a common initial symptom of systemic wild-type ATTR (ATTRwt) amyloidosis. Amyloid. 2016;23(1):58\u201363.","journal-title":"Amyloid"},{"key":"6853_CR67","unstructured":"Ng. The clinical course of transthyretin familial amyloid polyneuropathy with p.ala117ser mutation. In: International Society of Amyloidosis vol. XVII International Symposium on Amyloidosis. Spain; 2020 p. PM123."},{"key":"6853_CR68","first-page":"28","volume":"28","author":"FU Oike","year":"2021","unstructured":"Oike FU, Yamamoto H, Yamada E, Egashira T, Morioka K, Nishi M, Komorita M, Hirakawa T, Tabata K, Yamanaga N, Fujisue K, Hanatani K, Sueta S, Arima D, Araki Y, Takashio S, Oda S, Misumi S, Kawano Y, Matsushita H, Ueda K, Matsui M, Tsujita H. Prognostic value of left atrial strain in patients with wild-type transthyretin amyloid cardiomyopathy. ESC Heart Fail. 2021;28:28.","journal-title":"ESC Heart Fail"},{"issue":"4","key":"6853_CR69","first-page":"1485","volume":"24","author":"NJ Papoutsidakis","year":"2017","unstructured":"Papoutsidakis NJ, Rodonski D, Miller A. How soon is now? Delay in the utilization of technetium-99m pyrophosphate scintigraphy for the diagnosis of cardiac transthyretin amyloidosis in patients with symptoms. J Nuclear Cardiol. 2017;24(4):1485.","journal-title":"J Nuclear Cardiol"},{"issue":"S1","key":"6853_CR70","first-page":"S23","volume":"21","author":"FP Pastorelli","year":"2016","unstructured":"Pastorelli FP, Rapezzi R, Milletti C, Salvi DF. Neurophysiological assessment of senile systemic amyloidosis. J Peripheral Nerv Syst. 2016;21(S1):S23.","journal-title":"J Peripheral Nerv Syst."},{"issue":"SUPPL 1","key":"6853_CR71","first-page":"i459","volume":"22","author":"KS Patel","year":"2021","unstructured":"Patel KS, Nitsche P, Williams C, Tillin S, Captur T, Chako G, Newton L, Kennon J, Menezes S, Pugliese L, Fontana F, Treibel M, Mascherbauer TA, Moon J. AS-amyloidosis. Dual pathology or novel disease? A multimodality, multi-centre assessment across health and disease. Eur Heart J Cardiovasc Imaging. 2021;22(SUPPL 1):i459\u201360.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"4","key":"6853_CR72","first-page":"503","volume":"25","author":"AH Peltier","year":"2020","unstructured":"Peltier AH, Wigger R, Punnoose M, Slosky L. Spectrum of polyneuropathy observed in V122I inherited transthyretin amyloidosis patients. J Peripheral Nerv Syst. 2020;25(4):503\u20134.","journal-title":"J Peripheral Nerv Syst"},{"issue":"3","key":"6853_CR73","first-page":"345","volume":"26","author":"AD Peltier","year":"2021","unstructured":"Peltier AD, Ilieva U. Polyneuropathy characteristics in hATTR V122I patients: a multicenter perspective. J Peripheral Nerv Syst. 2021;26(3):345.","journal-title":"J Peripheral Nerv Syst"},{"key":"6853_CR74","doi-asserted-by":"crossref","first-page":"A59","DOI":"10.1136\/heartjnl-2011-300198.103","volume":"97","author":"JHL Pinney","year":"2011","unstructured":"Pinney JHL, Gillmore HJ, Wechalekar JD, Gibbs A, Sattianayagam SDJ, Banypersad P, Dungu SM, Wassef J, McCarthy N, Hawkins CA, Whelan PNCJ. Senile systemic amyloidosis: A common cause of heart failure in the elderly? Heart. 2011;97:A59\u201360.","journal-title":"Heart."},{"key":"6853_CR75","doi-asserted-by":"crossref","unstructured":"Plante-Bordeneuve VG, Hebrard F, Damy B, Ayache T, Nordine S, Lefaucheur TJP. Understand the disease emergence in hereditary transthyretin amyloidosis (hATTR): A longitudinal study of asymptomatic carriers to inaugural disease manifestations. Neurology. 2019;92(15 Supplement):P1.9-035.","DOI":"10.1212\/WNL.92.15_supplement.P1.9-035"},{"key":"6853_CR76","first-page":"528","volume":"1","author":"CL Quarta","year":"2013","unstructured":"Quarta CL, Cappelli S, Perfetti F, Ferlini F, Perlini A, Cinelli S, Gentile MM, Merlini N, Rapezzi G. Late onset cardiomyopathy due to transthyretin Ile68Leu mutation: a cardiogenic variant of familial amyloidosis potentially mimicking sarcomeric hypertrophic cardiomyopathy. Eur Heart J. 2013;1:528.","journal-title":"Eur Heart J"},{"issue":"Suppl 1","key":"6853_CR77","first-page":"165","volume":"12","author":"CCT Quarta","year":"2017","unstructured":"Quarta CCT, Gonzalez-Lopez AL, Lane E, Maurer T, Whelan M, Kristen CJ, Falk A, Damy RH, Garcia-Pavia T, Merlini P, Rapezzi G, Gillmore C, Hawkins JDPN. Characterization of wild-type transthyretin amyloidosis among women: Preliminary results from an international multicenter study. Orphanet J Rare Dis. 2017;12(Suppl 1):165.","journal-title":"Orphanet J Rare Dis."},{"issue":"SUPPL 2","key":"6853_CR78","first-page":"320","volume":"23","author":"RBC Rocio Ruiz Hueso","year":"2021","unstructured":"Rocio Ruiz Hueso RBC, Calvo Moron I, Bermudo Guitarte C, Aramburu Bodas C, Carmona Nimo O, Rico Corral E, Salamanca Bautista MA. Prevalence of cardiac amyloidosis in internal medicine patients with heart failure. Eur J Heart Fail. 2021;23(SUPPL 2):320.","journal-title":"Eur J Heart Fail"},{"key":"6853_CR79","unstructured":"Russo MS, Fabrizi C, Ferrarini GM, Gentile M, Vita L, Toscano G, Mazzeo AA. The transthyretin amyloidoses outcome survey (THAOS): record of patients from our site. J Peripheral Nerv Syst. 2011;3:S121."},{"issue":"4","key":"6853_CR80","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1529-8027.2012.00436.x","volume":"17","author":"MM Russo","year":"2012","unstructured":"Russo MM, Stancanelli A, Di Leo C, Gentile R, Di Bella L, Minutoli G, Baldari F, Vita S. Transthyretin-related familial amyloidotic polyneuropathy: description of a cohort of patients with Leu64 mutation and late onset. J Peripheral Nerv Syst. 2012;17(4):385\u201390.","journal-title":"J Peripheral Nerv Syst"},{"issue":"Supplement 1","key":"6853_CR81","first-page":"38","volume":"24","author":"MM Russo","year":"2019","unstructured":"Russo MM, Obici G, Pacciolla L, Fabrizi P, Cavallaro G, Sabatelli T, Luigetti M, Bisogni M, Pareyson G, Fenu D, Calabrese S, Rapezzi D, Bartolomei C, Grandis I, Gemelli M, Mauro C, Pradotto A, Santoro L, Manganelli L, Antonini F, Leonardi G, Vanoli L, My F, Gentile F, Stancanelli L, Mazzeo C, Vita A. Hattr Italian registry: preliminary data from the collaborative network of telethon gup 15010 study. J Peripheral Nerv Syst. 2019;24(Supplement 1):38\u2013S39.","journal-title":"J Peripheral Nerv Syst"},{"issue":"1","key":"6853_CR82","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00415-020-10127-8","volume":"268","author":"AC Salvalaggio","year":"2021","unstructured":"Salvalaggio AC, Cacciavillani D, Obici M, Mazzeo L, Luigetti A, Pastorelli M, Grandis F, Cavallaro M, Bisogni T, Lozza G, Gemelli A, Gentile C, Ermani L, Fabrizi M, Plasmati GM, Campagnolo R, Castellani M, Gasparotti F, Martinoli R, Padua C, Briani L. Nerve ultrasound in hereditary transthyretin amyloidosis: red flags and possible progression biomarkers. J Neurol. 2021;268(1):189\u201398.","journal-title":"J Neurol"},{"issue":"Suppl 1","key":"6853_CR83","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3109\/13506129.2012.682187","volume":"19","author":"FP Salvi","year":"2012","unstructured":"Salvi FP, Plasmati F, Bartolomei R, Dall\u2019Osso I, Rapezzi D. Genotypic and phenotypic correlation in an italian population of hereditary amyloidosis TTR-related (HA-TTR): clinical and neurophysiological aids to diagnosis and some reflections on misdiagnosis. Amyloid. 2012;19(Suppl 1):58\u201360.","journal-title":"Amyloid"},{"issue":"SUPPL G","key":"6853_CR84","first-page":"G18","volume":"22","author":"GG Saturi","year":"2020","unstructured":"Saturi GG, Caponetti C, Longhi A, Milandri S, Fabbri A, Ponziani G, Massa A, Sguazzotti P, Salvi M, Rapezzi FC. Role of gender in transthyretin-related amyloidosis: data from the thaos registry. Eur Heart J Supplement. 2020;22(SUPPL G):G18.","journal-title":"Eur Heart J Supplement"},{"issue":"11","key":"6853_CR85","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0735-1097(20)31371-1","volume":"75","author":"KBB Shah","year":"2020","unstructured":"Shah KBB, Gabriel N, Stevenson A, Cannon M, Khella C. Genetic testing for Hereditary Attr Amyloidosis: insights from the Hattr Compass Program. J Am Coll Cardiol. 2020;75(11):744.","journal-title":"J Am Coll Cardiol"},{"issue":"SUPPL 2","key":"6853_CR86","first-page":"245","volume":"23","author":"KK Shah","year":"2021","unstructured":"Shah KK, Delgado S, Keller D, Jefferies A, Towne J, Narayana M, Olugemo A. Symptom burden and clinical characteristics of patients with mutations associated with hereditary transthyretin amyloidosis: insights from referrals by cardiologists to a genetic testing programme. Eur J Heart Fail. 2021;23(SUPPL 2):245.","journal-title":"Eur J Heart Fail"},{"issue":"18 Supplement 1","key":"6853_CR87","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/S0735-1097(21)02101-X","volume":"77","author":"KBB Shah","year":"2021","unstructured":"Shah KBB, Delgado N, Keller D, Khella A, Gabriel S, Narayana A, Olugemo A. Characteristics of patients with P.V142i mutations Associated with Hereditary Transthyretin Amyloidosis: insights from a genetic testing program. J Am Coll Cardiol. 2021;77(18 Supplement 1):742.","journal-title":"J Am Coll Cardiol"},{"key":"6853_CR88","first-page":"04","volume":"04","author":"LHH Silva-Hernandez","year":"2020","unstructured":"Silva-Hernandez LHH, Valls Carbo A, Guerrero Sola A, Montalvo-Moraleda A, Galan Davila MT. Red flags in patients with hereditary transthyretin amyloidosis at diagnosis in a non-endemic area of Spain. Neurologia (Engl Ed). 2020;04:04.","journal-title":"Neurologia (Engl Ed)"},{"issue":"Supplement 2","key":"6853_CR89","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jval.2020.08.496","volume":"23","author":"MC Slama","year":"2020","unstructured":"Slama MC, Algalarrondo P, Lairez V, Pelcot O, Durand-Zaleski F, Lilliu I, Bartoli H, Famelart M, Fievez V, Geffroy S, de Neuville C, Rault B, Bourel C, Damy G. PCV5 clinical characteristics of patients with transthyretin amyloid cardiomyopathy (ATTR-CM) in France: EPACT, a study based on the French Nationwide Claims Database Snds. Value in Health. 2020;23(Supplement 2):486\u2013S487.","journal-title":"Value in Health"},{"issue":"1","key":"6853_CR90","first-page":"15","volume":"11","author":"ERS Soper","year":"2021","unstructured":"Soper ERS, Braganza SA, Kontorovich GT, Kenny AR, Abul-Husn EE. Genomic screening identifies individuals at high risk for Hereditary Transthyretin Amyloidosis. J Personalized Med. 2021;11(1):15.","journal-title":"J Personalized Med"},{"issue":"SUPPL 2","key":"6853_CR91","first-page":"17","volume":"23","author":"MSPBR Mariana Sousa Paiva","year":"2021","unstructured":"Mariana Sousa Paiva MSPBR, Christopher Strong BLR, Pedro Lopes CS, Goncalo Cunha PL, Catarina Brizido GC, Sergio Maltes CB, Carlos Aguiar SM, Miguel Mendes CA. Tracking Transthyretin Cardiac Amyloidosis: steps towards a tailored approach. Eur J Heart Fail. 2021;23(SUPPL 2):17\u20138.","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"6853_CR92","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1053\/euhj.1997.0841","volume":"19","author":"IHS-H Svendsen","year":"1998","unstructured":"Svendsen IHS-H, Nordvag F. A clinical, echocardiographic and genetic characterization of a danish kindred with familial amyloid transthyretin methionine 111 linked cardiomyopathy. Eur Heart J. 1998;19(5):782\u20139.","journal-title":"Eur Heart J"},{"key":"6853_CR93","doi-asserted-by":"crossref","unstructured":"Tzagournissakis MS, Amoiridis C, Plaitakis G, Mitsias AP. Familial amyloidotic polyneuropathy in Crete, Greece. Neurology. 2016;86(16 Supplement):P5.106.","DOI":"10.1212\/WNL.86.16_supplement.P5.106"},{"issue":"15 Supplement","key":"6853_CR94","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1212\/WNL.94.15_supplement.3974","volume":"94","author":"MF Tzagournissakis","year":"2020","unstructured":"Tzagournissakis MF, Marinis E, Mathioudakis A, Michaelidou L, Spanaki K, Tsilimbaris C, Plaitakis M, Mitsias A, Zaganas PI. High prevalence of transthyretin-related amyloidosis in Crete, Greece is due to three TTR pathogenic variants with markedly differing phenotypic presentations. Neurology. 2020;94(15 Supplement):3974.","journal-title":"Neurology."},{"issue":"9 Supplement 1","key":"6853_CR95","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/S0735-1097(19)31401-9","volume":"73","author":"ALH Warner","year":"2019","unstructured":"Warner ALH, Fazeli S, Berenji F, Ghaznavi G. Echocardiographic and electrocardiographic predictors of Transthyretin Cardiac Amyloidosis. J Am Coll Cardiol. 2019;73(9 Supplement 1):794.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"6853_CR96","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1002\/ehf2.12884","volume":"7","author":"TT Yamada","year":"2020","unstructured":"Yamada TT, Arima S, Nishi Y, Morioka M, Hirakawa M, Hanatani K, Fujisue S, Yamanaga K, Kanazawa K, Sueta H, Araki D, Usuku S, Nakamura H, Suzuki T, Yamamoto S, Ueda E, Kaikita M, Tsujita K. Clinical characteristics and natural history of wild-type transthyretin amyloid cardiomyopathy in Japan. ESC Heart Fail. 2020;7(5):2829\u201337.","journal-title":"ESC Heart Fail"},{"key":"6853_CR97","unstructured":"Yamashita TU, Nomura M, Okada T. N.: Amyloidosis typing at amyloidosis medical practice center in Kumamoto University hospital. In: International Society of Amyloidosis vol. XVII International Symposium on Amyloidosis. Spain; 2020. p. PM069"},{"key":"6853_CR98","unstructured":"Zadok. Prior carpal tunnel syndrome and early concomitant echocardiographic findings among patients with systemic amyloidosis. In: International Society of Amyloidosis vol. XVII International Symposium on Amyloidosis. Spain; 2020. p. PT075."},{"issue":"3","key":"6853_CR99","first-page":"404","volume":"26","author":"SS Zampino","year":"2021","unstructured":"Zampino SS, Vaishnav F, Judge J, Ebenezer D, Polydefkis G. Distinct clinical profiles among ATTRv genotypes. J Peripheral Nerv Syst. 2021;26(3):404.","journal-title":"J Peripheral Nerv Syst"},{"key":"6853_CR100","unstructured":"Zivkovic et al. Electrodiagnostic and clinical features of neuropathy in patients with wtATTR. In: International Society of Amyloidosis vol. XVII International Symposium on Amyloidosis. Spain; 2020. p. PW081."},{"key":"6853_CR101","first-page":"28","volume":"28","author":"HCG Backer","year":"2021","unstructured":"Backer HCG, Lentzsch SE, Freibott S, Shoap CE, Strauch S, Rosenwasser RJ. Flexor tenosynovectomy in carpal tunnel syndrome as a screening tool for early diagnosis of amyloidosis. Ir J Med Sci. 2021;28:28.","journal-title":"Ir J Med Sci"},{"key":"6853_CR102","unstructured":"Bastkj\u00e6r et al. The frequency of localised and systemic amyloidosis in patients receiving carpal tunnel release. In: International Society of Amyloidosis vol. XVII International Symposium on Amyloidosis. Spain; 2020. p. PM056."},{"issue":"2","key":"6853_CR103","first-page":"72","volume":"54","author":"SR Breda","year":"1993","unstructured":"Breda SR, Schachenmayr HP. [Incidence of biopsy-detectable amyloid deposits in the retinaculum flexorum and in the tenosynovial tissue in carpal tunnel syndrome]. Zentralbl Neurochir. 1993;54(2):72\u20136.","journal-title":"Zentralbl Neurochir"},{"issue":"5","key":"6853_CR104","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.medcli.2016.10.046","volume":"148","author":"JRV Fernandez Fuertes","year":"2017","unstructured":"Fernandez Fuertes JRV, Sanchez Herraez O, Ramos Pascua S. Early diagnosis of systemic amyloidosis by means of a transverse carpal ligament biopsy carried out during carpal tunnel syndrome surgery. Med Clin (Barc). 2017;148(5):211\u20134.","journal-title":"Med Clin (Barc)"},{"issue":"1","key":"6853_CR105","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jacc.2019.04.054","volume":"74","author":"ELR Fosbol","year":"2019","unstructured":"Fosbol ELR, Leicht R, Schou BP, Maurer M, Kristensen MS, Kober SL, Gustafsson L. Association of carpal tunnel syndrome with amyloidosis, heart failure, and adverse Cardiovascular Outcomes. J Am Coll Cardiol. 2019;74(1):15\u201323.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"6853_CR106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/13506129.2012.750604","volume":"20","author":"ZU Gioeva","year":"2013","unstructured":"Gioeva ZU, Meliss P, Haag RR, Axmann J, Siebert HD, Becker F, Radtke K, Rocken HG. ATTR amyloid in the carpal tunnel ligament is frequently of wildtype transthyretin origin. Amyloid. 2013;20(1):1\u20136.","journal-title":"Amyloid"},{"issue":"5","key":"6853_CR107","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/a-0747-6096","volume":"50","author":"KU Hahn","year":"2018","unstructured":"Hahn KU, Melis P, Axmann RR, Siebert HD, Rocken F. [Carpal tunnel syndrome and ATTR-amyloidosis]. Handchir Mikrochir Plast Chir. 2018;50(5):329\u201334.","journal-title":"Handchir Mikrochir Plast Chir"},{"issue":"SUPPL 2","key":"6853_CR108","first-page":"2126","volume":"41","author":"FGB Hansen","year":"2020","unstructured":"Hansen FGB, Nielsen R, Petersen SK, Moeller AS, Jensen HEH, Tromborg KP, Kejlaa H, Beck G, Rojek HC, Hansen AS, Marcussen CT, Overgaard N, Abildgaard S, Mogensen N. The frequency of cardiac amyloidosis in 182 patients receiving carpal tunnel release surgery. Eur Heart J. 2020;41(SUPPL 2):2126.","journal-title":"Eur Heart J"},{"issue":"11","key":"6853_CR109","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.cardfail.2020.06.009","volume":"26","author":"OA Itzhaki Ben Zadok","year":"2020","unstructured":"Itzhaki Ben Zadok OA, Vaxman A, Eisen I, Iakobishvili A, Sagie Z, Kornowski A, Vaturi R. Prior carpal tunnel syndrome and early concomitant echocardiographic findings among patients with Cardiac Amyloidosis. J Card Fail. 2020;26(11):909\u201316.","journal-title":"J Card Fail"},{"issue":"3","key":"6853_CR110","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/ejhf.1742","volume":"22","author":"AF Milandri","year":"2020","unstructured":"Milandri AF, Gagliardi A, Longhi C, Salvi S, Curti F, Foffi S, Caponetti S, Lorenzini AG, Ferlini M, Rimessi A, Mattioli P, Violante S, Rapezzi FS. Carpal tunnel syndrome in cardiac amyloidosis: implications for early diagnosis and prognostic role across the spectrum of aetiologies. Eur J Heart Fail. 2020;22(3):507\u201315.","journal-title":"Eur J Heart Fail"},{"issue":"10","key":"6853_CR111","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1002\/(SICI)1097-4598(199610)19:10<1349::AID-MUS16>3.0.CO;2-P","volume":"19","author":"KIT Nakamichi","year":"1996","unstructured":"Nakamichi KIT. Amyloid deposition in the synovium and ligament in idiopathic carpal tunnel syndrome. Muscle Nerve. 1996;19(10):1349\u201351.","journal-title":"Muscle Nerve"},{"issue":"9 Supplement 1","key":"6853_CR112","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jhsa.2017.06.064","volume":"42","author":"BAI Reyes","year":"2017","unstructured":"Reyes BAI, Sperry A, Shapiro B, Hanna DB, Seitz M. Carpal tunnel syndrome and amyloid cardiomyopathy. J Hand Surg. 2017;42(9 Supplement 1):31\u2013S32.","journal-title":"J Hand Surg"},{"issue":"2","key":"6853_CR113","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/13506129.2017.1313222","volume":"24","author":"RT Samoes","year":"2017","unstructured":"Samoes RT, Valdrez R, Goncalves K, Melo Pires I, Martins da Silva M, Coelho A. Amyloid detection in the transverse carpal ligament of patients with hereditary ATTR V30M amyloidosis and carpal tunnel syndrome. Amyloid. 2017;24(2):73\u20137.","journal-title":"Amyloid"},{"issue":"1","key":"6853_CR114","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/PRS.0000000000005090","volume":"143","author":"KLC Scott","year":"2019","unstructured":"Scott KLC, Renfree CR. Histopathologic evaluation of Flexor Tenosynovium in recurrent carpal tunnel syndrome. Plast Reconstr Surg. 2019;143(1):169\u201375.","journal-title":"Plast Reconstr Surg"},{"key":"6853_CR115","unstructured":"Sekijima YU, Tojo S, Sano K, Imaeda K, Kato T, Ikeda HS. Prevalence of senile systemic amyloidosis in patients with idiopathic carpal tunnel syndrome. Amyloid. 2010;17(S1):P-141."},{"issue":"11","key":"6853_CR116","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.humpath.2011.03.004","volume":"42","author":"YU Sekijima","year":"2011","unstructured":"Sekijima YU, Tojo S, Sano K, Shimizu K, Imaeda Y, Hoshii T, Kato Y, Ikeda H. High prevalence of wild-type transthyretin deposition in patients with idiopathic carpal tunnel syndrome: a common cause of carpal tunnel syndrome in the elderly. Hum Pathol. 2011;42(11):1785\u201391.","journal-title":"Hum Pathol"},{"issue":"1","key":"6853_CR117","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF00750729","volume":"412","author":"KS Stein","year":"1987","unstructured":"Stein KS, Linke S, Goebel RP. Chemical heterogeneity of amyloid in the carpal tunnel syndrome. Virchows Arch A Pathol Anat Histopathol. 1987;412(1):37\u201345.","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"issue":"6","key":"6853_CR118","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1253\/circrep.CR-21-0046","volume":"3","author":"KK Sugiura","year":"2021","unstructured":"Sugiura KK, Ueba H, Kubo H, Ochi T, Baba Y, Miyagawa Y, Noguchi K, Hirota T, Yamasaki T, Wada N, Nakashima N, Murakami J, Ikeuchi I, Kitaoka M. Tenosynovial and Cardiac Transthyretin amyloidosis in japanese patients undergoing carpal tunnel release. Circ Rep. 2021;3(6):338\u201344.","journal-title":"Circ Rep"},{"issue":"6","key":"6853_CR119","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s00776-014-0635-y","volume":"19","author":"SS Uchiyama","year":"2014","unstructured":"Uchiyama SS, Tojo Y, Sano K, Imaeda K, Moriizumi T, Ikeda T, Kato S. Effect of synovial transthyretin amyloid deposition on preoperative symptoms and postoperative recovery of median nerve function among patients with idiopathic carpal tunnel syndrome. J Orthop Sci. 2014;19(6):913\u20139.","journal-title":"J Orthop Sci"},{"issue":"SUPPL N","key":"6853_CR120","first-page":"N130","volume":"22","author":"PFP Vianello","year":"2020","unstructured":"Vianello PFP, Canepa I, Tini M, La Malfa G. Prevalence of transthyretin amyloid cardiomyopathy in male patients who underwent bilateral carpal tunnel surgery: the actual study. Eur Heart J Supplement. 2020;22(SUPPL N):N130.","journal-title":"Eur Heart J Supplement"},{"issue":"1","key":"6853_CR121","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12891-020-03912-z","volume":"22","author":"AEP Wininger","year":"2021","unstructured":"Wininger AEP, Le BM, Harris JT, Trachtenberg JD, Liberman BH. Musculoskeletal pathology as an early warning sign of systemic amyloidosis: a systematic review of amyloid deposition and orthopedic surgery. BMC Musculoskelet Disord. 2021;22(1):51.","journal-title":"BMC Musculoskelet Disord"},{"issue":"6","key":"6853_CR122","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s12265-019-09895-0","volume":"12","author":"FJ Zegri-Reiriz IdH-DM","year":"2019","unstructured":"Zegri-Reiriz IdH-DM FJ, Dominguez F, Salas C, de la Cuadra P, Plaza A, Krsnik I, Gonzalez-Lopez E, Garcia-Pavia P. Prevalence of Cardiac Amyloidosis in patients with carpal tunnel syndrome. J Cardiovasc Transl Res. 2019;12(6):507\u201313.","journal-title":"J Cardiovasc Transl Res"},{"issue":"Supplement 10","key":"6853_CR123","first-page":"3807","volume":"71","author":"ABH Arevalo","year":"2019","unstructured":"Arevalo ABH, Murray F, Contreras S, Luo G, Ali Y. Lumbar spinal stenosis in patients with wild-type transthyretin cardiac amyloidosis. Arthritis and Rheumatology. 2019;71(Supplement 10):3807\u20138.","journal-title":"Arthritis and Rheumatology"},{"issue":"S1","key":"6853_CR124","first-page":"S11","volume":"21","author":"AV Cortese","year":"2016","unstructured":"Cortese AV, Lozza E, Alfonsi A, Montini E, Moglia A, Merlini A, Obici GL. Diagnostic challenges in transthyretin amyloidosis: avoiding misdiagnosis of a treatable hereditary neuropathy. J Peripheral Nerv Syst. 2016;21(S1):S11-2.","journal-title":"J Peripheral Nerv Syst."},{"issue":"3","key":"6853_CR125","first-page":"147","volume":"11","author":"ANM D\u2019Agostino","year":"1992","unstructured":"D\u2019Agostino ANM, Quinn MS. Lumbar spinal stenosis and spondylosis associated with amyloid deposition in the ligamentum flavum. Clin Neuropathol. 1992;11(3):147\u201350.","journal-title":"Clin Neuropathol"},{"issue":"6","key":"6853_CR126","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/joim.13222","volume":"289","author":"PB Eldhagen","year":"2021","unstructured":"Eldhagen PB, Lund S, Sorensson LH, Suhr P, Westermark OB. Transthyretin amyloid deposits in lumbar spinal stenosis and assessment of signs of systemic amyloidosis. J Intern Med. 2021;289(6):895\u2013905.","journal-title":"J Intern Med"},{"issue":"2","key":"6853_CR127","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1017\/S0317167100040257","volume":"22","author":"F Gagne","year":"1995","unstructured":"Gagne F. Vertebral ligament amyloid deposits in spinal stenosis. [French]. Can J Neurol Sci. 1995;22(2):164\u20137.","journal-title":"Can J Neurol Sci"},{"issue":"1","key":"6853_CR128","first-page":"54","volume":"15","author":"UL Gies","year":"1996","unstructured":"Gies UL, Schachenmayr RP. Amyloid deposits of immunohistochemically different classes in the ligamentum flavum in biopsies from patients with herniated discs or lumbar spinal stenosis. Clin Neuropathol. 1996;15(1):54\u20139.","journal-title":"Clin Neuropathol"},{"key":"6853_CR129","unstructured":"Godara et al. Amyloid in the ligamentum flavum of patients with spinal stenosis and ATTR (wild-type) cardiac involvement. In: International Society of Amyloidosis vol. XVII International Symposium on Amyloidosis. Spain; 2020. p. PW089"},{"issue":"3","key":"6853_CR130","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/03009734.2014.895786","volume":"119","author":"PW Westermark","year":"2014","unstructured":"Westermark PW, Suhr GT, Berg OB. Transthyretin-derived amyloidosis: probably a common cause of lumbar spinal stenosis. Ups J Med Sci. 2014;119(3):223\u20138.","journal-title":"Ups J Med Sci"},{"issue":"2","key":"6853_CR131","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/modpathol.2014.102","volume":"28","author":"AU Yanagisawa","year":"2015","unstructured":"Yanagisawa AU, Sueyoshi M, Okada T, Fujimoto T, Ogi T, Kitagawa Y, Tasaki K, Misumi M, Oshima Y, Jono T, Obayashi H, Hirakawa K, Uchida K, Westermark H, Ando P, Mizuta Y. Amyloid deposits derived from transthyretin in the ligamentum flavum as related to lumbar spinal canal stenosis. Mod Pathol. 2015;28(2):201\u20137.","journal-title":"Mod Pathol"},{"issue":"11","key":"6853_CR132","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0735-1097(20)31447-9","volume":"75","author":"AC Abboud","year":"2020","unstructured":"Abboud AC, Nguonly A, Fiseha A, Bean N, Osborne A, Ibrahim MT, McCarthy NE, Tawakol CP, Ruberg A, Sadjadi FL, David R, Lewis WS, Januzzi GD, Gaggin JL. Care Trajectory and early clinical features among patients with 99mtc-Pyrophosphate positive transthyretin amyloid cardiomyopathy (Attr-Cm). J Am Coll Cardiol. 2020;75(11):820.","journal-title":"J Am Coll Cardiol"},{"issue":"SUPPL 2","key":"6853_CR133","first-page":"250","volume":"23","author":"XG Arana","year":"2021","unstructured":"Arana XG, Villanueva C, Rengel I, Manas A, Rilo L, Solla I, Querejeta I. Transthyretin cardiac amyloidosis: what are the main clinical suspicion data? Eur J Heart Fail. 2021;23(SUPPL 2):250.","journal-title":"Eur J Heart Fail"},{"issue":"7","key":"6853_CR134","first-page":"14","volume":"9","author":"MR Auer-Grumbach","year":"2020","unstructured":"Auer-Grumbach MR, Ablasser R, Agis K, Beetz H, Duca C, Gattermeier F, Glaser M, Hacker F, Kain M, Kaufmann R, Kovacs B, Lampl GG, Ljevakovic C, Nagele N, Polzl J, Quasthoff G, Raimann S, Rauschka B, Reiter H, Skrahina C, Schuhfried V, Sunder-Plassmann O, Verheyen R, Wanschitz ND, Weber J, Windhager T, Wurm R, Zimprich R, Loscher F, Bonderman WN. Hereditary ATTR Amyloidosis in Austria: Prevalence and Epidemiological Hot Spots. J. 2020;9(7):14.","journal-title":"J"},{"key":"6853_CR135","doi-asserted-by":"crossref","unstructured":"Aus dem Siepen FH, Prestel S, Baumgartner S, Schonland C, Hegenbart S, Rocken U, Katus C, Kristen HA. A. V.: Carpal tunnel syndrome and spinal canal stenosis: harbingers of transthyretin amyloid cardiomyopathy? Clin 2019, 108(12):1324\u201330.","DOI":"10.1007\/s00392-019-01467-1"},{"issue":"15 Supplement","key":"6853_CR136","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1212\/WNL.94.15_supplement.2888","volume":"94","author":"SK Bhadola","year":"2020","unstructured":"Bhadola SK, Lau MKHV. Neurological manifestations in patients with hereditary transthyretin amyloidosis: A retrospective database study based at a major multidisciplinary amyloidosis center. Neurology. 2020;94(15 Supplement):2888.","journal-title":"Neurology."},{"issue":"10 Supplement","key":"6853_CR137","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cardfail.2020.09.100","volume":"26","author":"SM Bukhari","year":"2020","unstructured":"Bukhari SM, Shpilsky S, Nieves D, Soman R. Amyloidosis prediction score: a clinical model for diagnosing Transthyretin Cardiac Amyloidosis. J Card Fail. 2020;26(10 Supplement):33.","journal-title":"J Card Fail"},{"issue":"5","key":"6853_CR138","first-page":"1071","volume":"69","author":"SM Bukhari","year":"2021","unstructured":"Bukhari SM, Shpilsky S, Nieves D, Bashir R, Soman Z. Development and validation of a diagnostic model and scoring system for transthyretin cardiac amyloidosis. J Investig Med. 2021;69(5):1071\u20132.","journal-title":"J Investig Med"},{"issue":"4","key":"6853_CR139","first-page":"555","volume":"25","author":"MC Campagnolo","year":"2020","unstructured":"Campagnolo MC, Cacciavillani C, Berno M, Salvalaggio T, Cipriani A, Castellani A, Briani F. Wild-type transthyretin amyloidosis: Clinical, Neurophysiological and Imaging Profile. J Peripheral Nerv Syst. 2020;25(4):555.","journal-title":"J Peripheral Nerv Syst"},{"issue":"9","key":"6853_CR140","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1080\/00015385.2021.1976450","volume":"77","author":"PC Debonnaire","year":"2022","unstructured":"Debonnaire PC, De Smet M, Trenson M, Lycke S, Demeester M, Van Droogenbroeck C, De Vriese J, Verhoeven AS, Vantomme K, Van Meirhaeghe N, Willandt J, Lambert B, de Paepe M, Delanote P, De Geeter J, Tavernier FR. Trends in diagnosis, referral, red flag onset, patient profiles and natural outcome of de novo cardiac amyloidosis and their multidisciplinary implications. Acta Cardiol. 2022;77(9):791\u2013804.","journal-title":"Acta Cardiol."},{"key":"6853_CR141","doi-asserted-by":"crossref","unstructured":"Di Stefano VT, Giustino E, Gagliardo V, Lupica A, Iacono A, Palma S, Battaglia A, Brighina GF. Bioimpedance analysis as a marker for disease progression in hereditary transthyretin amyloidosis with polyneuropathy. J Neurol Sci. 2021;429(Supplement):118376.","DOI":"10.1016\/j.jns.2021.118376"},{"issue":"Suppl 1","key":"6853_CR142","doi-asserted-by":"crossref","first-page":"P33","DOI":"10.1186\/1750-1172-10-S1-P33","volume":"10","author":"HM Durmus","year":"2015","unstructured":"Durmus HM, Atmaca Z, Poda MM, Cakar M, Serdaroglu-Oflazer A, Deymeer P, Parman FY. Genotypic and phenotypic presentation of GLU89GLN mutation in Turkey. Orphanet J Rare Dis. 2015;10(Suppl 1):P33.","journal-title":"Orphanet J Rare Dis."},{"issue":"3","key":"6853_CR143","first-page":"276","volume":"22","author":"HC Durmus","year":"2017","unstructured":"Durmus HC, Sahin A, Matur E, Poda Z, Altunoglu M, Oflazer-Serdaroglu U, Deymeer P, Parman F. Genotypic and phenotypic presentation of transthyretin-related familial amyloid polyneuropathy (TTR-FAP) in Turkey. J Peripheral Nerv Syst. 2017;22(3):276\u20137.","journal-title":"J Peripheral Nerv Syst"},{"issue":"8 Supplement","key":"6853_CR144","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cardfail.2019.07.151","volume":"25","author":"AS Huda","year":"2019","unstructured":"Huda AS, Castano SJ, Niyogi A, Schumacher A, Stewart J, Deo M. A machine learning model for the systematic identification of wild-type transthyretin cardiomyopathy. J Card Fail. 2019;25(8 Supplement):53\u2013S54.","journal-title":"J Card Fail"},{"issue":"2","key":"6853_CR145","first-page":"10","volume":"8","author":"RELH Lauppe","year":"2021","unstructured":"Lauppe RELH, Gerdeskold J, Rozenbaum C, Strand MH, Vakevainen AM, Kuusisto M, Gude J, Gustafsson E, Smith F. Nationwide prevalence and characteristics of transthyretin amyloid cardiomyopathy in Sweden. Open Heart. 2021;8(2):10.","journal-title":"Open Heart"},{"issue":"18 Supplement 1","key":"6853_CR146","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0735-1097(21)02198-7","volume":"77","author":"TS Martyn","year":"2021","unstructured":"Martyn TS, Estep J, Collier J, Kwon P, Jaber D, Hanna W, Tang M. The Use of Natural Language Processing Tools and the Integrated Electronic Medical Record (Emr) to identify patients at high-risk for Transthyretin Cardiac Amyloidosis. J Am Coll Cardiol. 2021;77(18 Supplement 1):839.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"6853_CR147","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/13506129.2020.1794807","volume":"27","author":"MO Russo","year":"2020","unstructured":"Russo MO, Bartolomei L, Cappelli I, Luigetti F, Fenu M, Cavallaro S, Chiappini T, Gemelli MG, Pradotto C, Manganelli LG, Leonardi F, My L, Sampaolo F, Briani S, Gentile C, Stancanelli L, Di Buduo C, Pacciolla E, Salvi P, Casagrande F, Bisogni S, Calabrese G, Vanoli D, Di Iorio F, Antonini G, Santoro G, Mauro L, Grandis A, Di Girolamo M, Fabrizi M, Pareyson GM, Sabatelli D, Perfetto M, Rapezzi F, Merlini C, Mazzeo G, Vita A. ATTRv amyloidosis Italian Registry: clinical and epidemiological data. Amyloid. 2020;27(4):259\u201365.","journal-title":"Amyloid"},{"issue":"5","key":"6853_CR148","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1017\/cjn.2020.271","volume":"48","author":"AH Russell","year":"2021","unstructured":"Russell AH, Chhibber C, Korngut S, Fine L. Utility of Neuropathy Screening for Wild-Type Transthyretin Amyloidosis Patients. Can J Neurol Sci. 2021;48(5):607\u201315.","journal-title":"Can J Neurol Sci"},{"key":"6853_CR149","doi-asserted-by":"crossref","first-page":"e325","DOI":"10.1016\/j.wneu.2020.06.228","volume":"142","author":"KMD George","year":"2020","unstructured":"George KMD, Nail RS, Yu J, Mastroianni A, Wang M, Arkun AY, Patel K, Kryzanski A, Comenzo J, Riesenburger R. Wild-type Transthyretin Amyloidosis Occurring in the Ligamentum Flavum of the Cervicothoracic spine. World Neurosurg. 2020;142:e325\u201330.","journal-title":"World Neurosurg"},{"key":"6853_CR150","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jocn.2020.11.029","volume":"84","author":"KMH George","year":"2021","unstructured":"George KMH, Breton NS, Cooper J, Dowd B, Nail RS, Yu J, Mastroianni A, Wang M, Godara A, Zhang A, Arkun D, Patel K, Varga AR, Soto C, Kryzanski O, Comenzo J, Riesenburger R. Increased thickness of lumbar spine ligamentum flavum in wild-type transthyretin amyloidosis. J Clin Neurosci. 2021;84:33\u20137.","journal-title":"J Clin Neurosci"},{"key":"6853_CR151","doi-asserted-by":"crossref","first-page":"106708","DOI":"10.1016\/j.clineuro.2021.106708","volume":"206","author":"KMH George","year":"2021","unstructured":"George KMH, Breton NS, Cooper J, Dowd B, Nail RS, Yu J, Mastroianni A, Wang M, Godara A, Zhang A, Arkun D, Patel K, Varga AR, Soto C, Kryzanski O, Comenzo J, Riesenburger R. Lumbar ligamentum flavum burden: evaluating the role of ATTRwt amyloid deposition in ligamentum flavum thickness at all lumbar levels. Clin Neurol Neurosurg. 2021;206:106708.","journal-title":"Clin Neurol Neurosurg"},{"key":"6853_CR152","first-page":"1","volume":"4","author":"AR Godara","year":"2021","unstructured":"Godara AR, Zhang RI, Varga DX, Fogaren C, Siddiqui T, Yu NS, Wang A, Mastroianni A, Dowd M, Nail R, McPhail TJ, Kurtin ED, Theis PJ, Toskic JD, Arkun D, Pilichowska K, Kryzanski M, Patel J, Comenzo ARR. Association between spinal stenosis and wild-type ATTR amyloidosis. Amyloid. 2021;4:1\u20138.","journal-title":"Amyloid."},{"issue":"8","key":"6853_CR153","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1002\/art.39178","volume":"67","author":"Y Akasaki","year":"2015","unstructured":"Akasaki Y, Reixach N, Matsuzaki T, Alvarez-Garcia O, Olmer M, Iwamoto Y, Buxbaum JN, Lotz MK. Transthyretin deposition in articular cartilage: a novel mechanism in the pathogenesis of osteoarthritis. Arthritis & Rheumatology. 2015;67(8):2097\u2013107.","journal-title":"Arthritis & Rheumatology"},{"key":"6853_CR154","doi-asserted-by":"crossref","unstructured":"Akasaki YA-G, Reixach O, Buxbaum N, Iwamoto J, Lotz YMK. Transthyretin and amyloid in cartilage aging and osteoarthritis. Arthritis Rheumatol. 2014;(10):S452.","DOI":"10.1016\/j.joca.2015.02.985"},{"issue":"S1","key":"6853_CR155","first-page":"1538","volume":"35","author":"YL Akasaki","year":"2017","unstructured":"Akasaki YL, Matsuzaki MK, Alvarez-Garcia T, Okazaki O, Nakashima KY. Transthyretin and amyloid deposition in osteoarthritis. J Orthop Res Conf. 2017;35(S1):1538.","journal-title":"J Orthop Res Conf."},{"issue":"2","key":"6853_CR156","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/art.1780250214","volume":"25","author":"MSG Egan","year":"1982","unstructured":"Egan MSG, Cohen DL, Segal AS. The association of amyloid deposits and osteoarthritis. Arthritis Rheum. 1982;25(2):204\u20138.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"6853_CR157","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1631\/jzus.B1300046","volume":"15","author":"YJG Gu","year":"2014","unstructured":"Gu YJG, Mu P, Lu Y, Zheng JH, Sun F. Clinical and laboratory characteristics of patients having amyloidogenic transthyretin deposition in osteoarthritic knee joints. J Zhejiang Univ Sci B. 2014;15(1):92\u20139.","journal-title":"J Zhejiang Univ Sci B"},{"issue":"5","key":"6853_CR158","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s00402-010-1187-z","volume":"131","author":"OS Niggemeyer","year":"2011","unstructured":"Niggemeyer OS, Deuretzbacher J, Zustin G, Ruther J. Amyloid deposition in osteoarthritis of the hip. Arch Orthop Trauma Surg. 2011;131(5):637\u201343.","journal-title":"Arch Orthop Trauma Surg"},{"issue":"3","key":"6853_CR159","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3109\/13506129.2013.803190","volume":"20","author":"TM Takanashi","year":"2013","unstructured":"Takanashi TM, Yazaki M, Yamazaki M, Nawata H, Katagiri M, Ikeda Y. Synovial deposition of wild-type transthyretin-derived amyloid in knee joint osteoarthritis patients. Amyloid. 2013;20(3):151\u20135.","journal-title":"Amyloid"},{"issue":"1","key":"6853_CR160","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3109\/13506129.2015.1115758","volume":"23","author":"AU Yanagisawa","year":"2016","unstructured":"Yanagisawa AU, Sueyoshi M, Nakamura T, Tasaki E, Suenaga M, Motokawa G, Toyoshima H, Kinoshita R, Misumi Y, Yamashita Y, Sakaguchi T, Westermark M, Mizuta P, Ando H. Knee osteoarthritis associated with different kinds of amyloid deposits and the impact of aging on type of amyloid. Amyloid. 2016;23(1):26\u201332.","journal-title":"Amyloid"},{"issue":"SUPPL 1","key":"6853_CR161","first-page":"528","volume":"47","author":"AB Paccagnella","year":"2020","unstructured":"Paccagnella AB, Mattana R, Mei F, Saturi R, Massa G, Caponetti P, Sguazzotti G, Ponziani M, Gagliardi A, Longhi C, Galie S, Fanti N. Prevalence of transthyretin cardiac amyloidosis (ATTRCA) in a population of patients with hip and knee arthroplasty: could they be early signs? Eur J Nucl Med Mol Imaging. 2020;47(SUPPL 1):528.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8 Supplement 1","key":"6853_CR162","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cardfail.2017.07.069","volume":"23","author":"JA Rubin","year":"2017","unstructured":"Rubin JA, Teruya J, Castano S, Lehman A, Weidenbaum RA, Geller M, Helmke JA, Maurer S. Hip and knee arthroplasty are common among transthyretin cardiac amyloidosis patients and occur 7.6 years before cardiac amyloid diagnosis: can we identify affected patients earlier? J Card Fail. 2017;23(8 Supplement 1):27.","journal-title":"J Card Fail"},{"key":"6853_CR163","unstructured":"Campbell C et al. Orthopaedics history preceding diagnosis of cardiac amyloidosis: Timing and variation by subtype. In: International Society of Amyloidosis vol. XVII International Symposium on Amyloidosis. Spain; 2020. p. PT119."},{"issue":"SUPPL. 3","key":"6853_CR164","first-page":"A12716","volume":"132","author":"HIT Geller","year":"2015","unstructured":"Geller HIT, Falk DRH. Ruptured biceps tendon: A novel non-cardiac clue to TTR cardiac amyloidosis. Circulation. 2015;132(SUPPL. 3):A12716.","journal-title":"Circulation."},{"key":"6853_CR165","unstructured":"Gorevic PD. Cardiac amyloidosis at Mount Sinai: review of 164 cases with special reference to Associated arthropathy, neuropathy, myopathy and gammopathy. In: International Society of Amyloidosis vol. XVII International Symposium on Amyloidosis. Spain; 2020. p. PT135."},{"key":"6853_CR166","unstructured":"Kastritis E, et al. Diagnosis and clinical characteristics of patients with wtATTR cardiomyopathy: a systemic disease beyond the heart. In: International Society of Amyloidosis vol. XVII International Symposium on Amyloidosis. Spain; 2020. p. PW092."},{"key":"6853_CR167","unstructured":"Kogan R, et al. Prevalence and clinical significance of orthopedic red flags in cardiac amyloidosis. In: International Society of Amyloidosis vol. XVII International Symposium on Amyloidosis. Spain; 2020. p. PT099."},{"key":"6853_CR168","unstructured":"Nativi-Nicolau J et al. Wild-type transthyretin, more than what meets the heart. In: International Society of Amyloidosis vol. XVII International Symposium on Amyloidosis. Spain; 2020. p. PW083."},{"key":"6853_CR169","unstructured":"Rapezzi et al. The incidence and temporal relationship of early clinical manifestations and transthyretin amyloid cardiomyopathy in tafamidis clinical trials. In: International Society of Amyloidosis vol. XVII International Symposium on Amyloidosis. Spain; 2020. p. PT086."},{"issue":"4","key":"6853_CR170","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1080\/13506129.2017.1375908","volume":"24","author":"JA Rubin","year":"2017","unstructured":"Rubin JA, Teruya J, Castano S, Lehman A, RA Weidenbaum, Geller M, Helmke JA, Maurer S. M. S. Hip and knee arthroplasty are common among patients with transthyretin cardiac amyloidosis, occurring years before cardiac amyloid diagnosis: can we identify affected patients earlier? Amyloid. 2017;24(4):226\u201330.","journal-title":"Amyloid"},{"issue":"1","key":"6853_CR171","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1080\/13506129.2017.1409706","volume":"25","author":"YY Sekijima","year":"2018","unstructured":"Sekijima YY, Ueda M, Koike M, Yamada H, Ando M. First nationwide survey on systemic wild-type ATTR amyloidosis in Japan. Amyloid. 2018;25(1):8\u201310.","journal-title":"Amyloid"},{"issue":"18 Supplement 1","key":"6853_CR172","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0735-1097(21)02036-2","volume":"77","author":"CK Willis","year":"2021","unstructured":"Willis CK, Watanabe K, Biskupiak A, Nolen J, Blackner K, Bruno L, Ateya M, Schepart M, Nativi-Nicolau A. Screening of patients at risk for wild type Attr-Cm using a computational machine learning algorithm. J Am Coll Cardiol. 2021;77(18 Supplement 1):677.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"6853_CR173","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1142\/S2424835520500381","volume":"25","author":"YT Hara","year":"2020","unstructured":"Hara YT, Kawano Y, Hoshikawa K, Kita S. The Tenosynovitis of Fingers Associated with Transthyretin Amyloidosis. J Hand Surg Asian Pac Vol. 2020;25(3):340\u20134.","journal-title":"J Hand Surg Asian Pac Vol"},{"issue":"14","key":"6853_CR174","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.2106\/JBJS.20.02093","volume":"103","author":"RFK Sood","year":"2021","unstructured":"Sood RFK, McCreary S, Sather E, Schmitt BK, Peterson M, Lipira SL. Diagnosing systemic amyloidosis presenting as carpal tunnel syndrome: a risk nomogram to Guide Biopsy at Time of carpal tunnel release. J Bone Joint Surg Am. 2021;103(14):1284\u201394.","journal-title":"J Bone Joint Surg Am"},{"key":"6853_CR175","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.amjcard.2021.08.049","volume":"160","author":"BWK Sperry","year":"2021","unstructured":"Sperry BWK, Gabrovsek R, Donnelly A, Kilpatrick JP, Shapiro S, Evans D, Maschke PJ, Cotta S, Nakashima C, Seitz M, Hanna W. Cardiac amyloidosis screening at trigger finger release surgery. Am J Cardiol. 2021;160:96\u20138.","journal-title":"Am J Cardiol"},{"key":"6853_CR176","doi-asserted-by":"crossref","unstructured":"Sperry BWR, Ikram BA, Donnelly A, Phelan JP, Jaber D, Shapiro WA, Evans D, Maschke PJ, Kilpatrick S, Tan SE, Rodriguez CD, Monteiro ER, Tang C, Kelly WHW, Seitz JW. W. H., Jr. Hanna, M.: Tenosynovial and Cardiac Amyloidosis in Patients Undergoing Carpal Tunnel Release. Journal of the American College of Cardiology 2018, 72(17):2040\u20132050.","DOI":"10.1016\/j.jacc.2018.07.092"},{"issue":"9","key":"6853_CR177","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.humpath.2010.11.017","volume":"42","author":"TU Sueyoshi","year":"2011","unstructured":"Sueyoshi TU, Jono M, Irie H, Sei H, Ide A, Ando J, Mizuta Y. Wild-type transthyretin-derived amyloidosis in various ligaments and tendons. Hum Pathol. 2011;42(9):1259\u201364.","journal-title":"Hum Pathol"},{"issue":"Supplement 1","key":"6853_CR178","first-page":"405","volume":"27","author":"LC Leon Cejas","year":"2020","unstructured":"Leon Cejas LC, Conti C, Aguirre ME, Rodriguez F, Landricina A, Pedelhez P, Cordoba R, Chaves M, Rugiero M, Marchesoni M, Pardal C, Barroso A, Reisin F. Argentinean study in transthyretin familial amyloid polyneuropathy. An old illness that we need to think. Eur J Neurol. 2020;27(Supplement 1):405.","journal-title":"Eur J Neurol"},{"key":"6853_CR179","unstructured":"JBI Manual for Evidence Synthesis. [https:\/\/jbi-global-wiki.refined.site\/space\/MANUAL]."},{"issue":"8","key":"6853_CR180","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cardfail.2019.07.031","volume":"25","author":"M Grogan","year":"2019","unstructured":"Grogan M, Hawkins PN, Kristen AV, Berk JL, Suhr OB, Lin H, Merkel M, McManus A, Powell C, Vest J, et al. Identifying mixed phenotype: evaluating the Presence of Polyneuropathy in patients with Hereditary transthyretin-mediated amyloidosis with cardiomyopathy. J Card Fail. 2019;25(8):9\u2013S10.","journal-title":"J Card Fail"},{"issue":"4","key":"6853_CR181","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.jaccao.2021.06.006","volume":"3","author":"JM Griffin","year":"2021","unstructured":"Griffin JM, Rosenthal JL, Grodin JL, Maurer MS, Grogan M, Cheng RK. ATTR Amyloidosis: current and emerging management strategies: JACC: CardioOncology State-of-the-art review. JACC CardioOncol. 2021;3(4):488\u2013505.","journal-title":"JACC CardioOncol"},{"issue":"2","key":"6853_CR182","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.cardfail.2017.12.005","volume":"24","author":"N Papoutsidakis","year":"2018","unstructured":"Papoutsidakis N, Miller EJ, Rodonski A, Jacoby D. Time Course of Common Clinical Manifestations in patients with Transthyretin Cardiac Amyloidosis: Delay from Symptom Onset to diagnosis. J Card Fail. 2018;24(2):131\u20133.","journal-title":"J Card Fail"},{"issue":"2","key":"6853_CR183","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2559.1991.tb00008.x","volume":"19","author":"LM Looi","year":"1991","unstructured":"Looi LM. Dystrophic amyloidosis: a local complication of tissue damage with heterogeneous distribution. Histopathology. 1991;19(2):169\u201372.","journal-title":"Histopathology"},{"issue":"10","key":"6853_CR184","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.jacc.2022.06.026","volume":"80","author":"O Westin","year":"2022","unstructured":"Westin O, Fosb\u00f8l Emil L, Maurer Mathew S, Leicht Birgitte P, Hasbak P, Mylin Anne K, R\u00f8rvig S, Lindk\u00e6r Thomas H, Johannesen Helle H, Gustafsson F. Screening for Cardiac Amyloidosis 5 to 15 years after surgery for bilateral carpal tunnel syndrome. J Am Coll Cardiol. 2022;80(10):967\u201377.","journal-title":"J Am Coll Cardiol"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-023-06853-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12891-023-06853-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-023-06853-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T10:59:28Z","timestamp":1703242768000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-023-06853-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,22]]},"references-count":184,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["6853"],"URL":"https:\/\/doi.org\/10.1186\/s12891-023-06853-5","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,22]]},"assertion":[{"value":"27 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable this is a secondary analysis of primary research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable this is a secondary analysis of primary research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Catherine Summers and Emre Aldinc are employees of Alnylam Pharmaceuticals. Finn Gustafsson is an adviser to Alnylam, Ionis and Pfizer. Courtney Campbell is an adviser to Alnylam and Pfizer and has received research support from Alnylam and Akari Therapeutics. Richard Macey, Abigail Beveridge, and Laura Marr are employees of Adelphi Values PROVE\u2122. Adelphi Values PROVE\u2122 received funding from Alnylam Pharmaceuticals for the conduct of the review, from development of the systematic review methodology through to overseeing the final formatting and manuscript submission processes.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"751"}}